Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression

Prostate

Volumn 70, Issue 15, 2010, Pages 1672-1682

  Lindholm, Paul F ^a   Lu, Yi ^b   Adley, Brian P ^a,c   Vladislav, Tudor ^b   Jovanovic, Borko ^a   Sivapurapu, Neela ^a   Yang, Ximing J ^a   Kajdacsy Balla, André ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

Author keywords

Invasion; Monocytes; Prostate cancer; Tissue factor

Indexed keywords

CD68 ANTIGEN; NEUTRALIZING ANTIBODY; THROMBOPLASTIN; C5AR1 PROTEIN, HUMAN; COMPLEMENT RECEPTOR;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CELL ACTIVITY; CELL FUNCTION; CELL INVASION; CELL LINEAGE; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRAIN U937; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; STROMA CELL; ADENOCARCINOMA; BIOSYNTHESIS; CELL GROWTH; CELL MOTION; COCULTURE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TISSUE MICROARRAY; TUMOR CELL LINE;

ADENOCARCINOMA; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTES; PROSTATIC NEOPLASMS; RECEPTORS, COMPLEMENT; STATISTICS, NONPARAMETRIC; THROMBOPLASTIN; TISSUE ARRAY ANALYSIS;

EID: 77958468844     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21202     Document Type: Article

References (78)

1. Karan D, Holzbeierlein J, Thrasher JB,. Macrophage inhibitory cytokine-1: Possible bridge molecule of inflammation and prostate cancer. Cancer Res 2009; 69 (1): 2 -5.
2. Yu JL, Rak JW,. Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Br Cancer Res 2003; 5 (2): 83 -88.
3. Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S, Kuwano M,. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFalpha and IL-1alpha. Int J Cancer 2000; 85 (2): 182 -188.
4. Balkwill F, Mantovani A,. Inflammation and cancer: Back to Virchow? Lancet 2001; 357 (9255): 539 -545.
5. Kuper H, Adami HO, Trichopoulos D,. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248 (3): 171 -183.
6. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420 (6917): 860 -867.
7. Ernst PB, Gold BD,. The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer. Ann Rev Microbiol 2000; 54: 615 -640.
8. Shacter E, Weitzman SA,. Chronic inflammation and cancer. Oncology 2002; 16 (2): 217 -226.
9. Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM, Greenberg RS, Schoenberg JB, Liff J, Schwartz AG, Hoover RN, Fraumeni JF Jr., Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 2000; 82 (3): 718 -725.
10. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG,. Human prostate cancer precursors and pathobiology. Urology 2003; 62 (5 Supplement 1): 55 -62.
11. Platz EA, De Marzo AM,. Epidemiology of inflammation and prostate cancer. J Urology 2004; 171 (2 Pt 2): S36 -S40.
12. De Marzo AM, Nakai Y, Nelson WG, Inflammation, atrophy, and prostate carcinogenesis. Urology 2007; 25 (5): 398 -400.
13. Liotta LA, Kohn EC,. The microenvironment of the tumour-host interface. Nature 2001; 411 (6835): 375 -379.
14. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Gronberg H,. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: Results from the CAncer Prostate in Sweden Study. Cancer Res 2004; 64 (8): 2918 -2922.
15. Blum DL, Koyama T, M'Koma AE, Iturregui JM, Martinez-Ferrer M, Uwamariya C, Smith JA Jr, Clark PE, Bhowmick NA,. Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clin Cancer Res 2008; 14 (23): 7790 -7797.
16. Allavena P, Sica A, Solinas G, Porta C, Mantovani A,. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008; 66 (1): 1 -9.
17. Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN,. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004; 101 (12): 2779 -2787.
18. Liu S-Y, Chang L-C, Pan L-F, Hung Y-J, Lee C-H, Shieh Y-S,. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 2008; 44 (3): 277 -285.
19. Moser PL, Brunner A, Horninger W, Bartsch G, Mikuz G,. Correlation between inflammatory cells (T and B lymphocytes, macrophages) in prostate biopsies and elevated PSA levels in a PSA screening population. Urology 2002; 59 (1): 68 -72.
20. Yang G, Addai J, Tian W-H, Frolov A, Wheeler TM, Thompson TC,. Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression. Cancer Res 2004; 64 (6): 2076 -2082.
21. Mantovani A,. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines. Lab Invest 1994; 71 (1): 5 -16.
22. Reiland J, Furcht LT, McCarthy JB,. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 1999; 41 (2): 78 -88.
23. Wang W, Bergh A, Damber JE,. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 2005; 11 (9): 3250 -3256.
24. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC,. Tumor-associated macrophages: The double-edged sword in cancer progression. J Clin Oncol 2005; 23 (5): 953 -964.
25. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M,. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118 (3): 285 -296.
26. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M,. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 2004; 6 (3): 297 -305.
27. Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH,. Role of tissue factor in metastasis: Functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 1999; 82 (1): 88 -92.
28. Oeth P, Parry GC, Mackman N,. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler ThrombVasc Biol 1997; 17 (2): 365 -374.
29. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, Nakamura S, Shiku H,. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69 (4): 247 -254.
30. Koomagi R, Volm M,. Tissue-factor expression in human non-small cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis. Int J Cancer 1998; 79 (1): 19 -22.
31. Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, Milbrandt J,. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000; 31 (4): 443 -447.
32. Akashi T, Furuya Y, Ohta S, Fuse H,. Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology 2003; 62 (6): 1078 -1082.
33. Martin DM, Boys CW, Ruf W,. Tissue factor: Molecular recognition and cofactor function. FASEB J 1995; 9 (10): 852 -859.
34. Hillen HF,. Thrombosis in cancer patients. Ann Oncol 2000; 11 (Suppl 3): 273 -276.
35. Lykke J, Nielsen HJ,. The role of tissue factor in colorectal cancer. Eur J Surg Oncol 2003; 29 (5): 417 -422.
36. Shigemori C, Wada H, Matsumoto K, Shiku H, Nakamura S, Suzuki H,. Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost 1998; 80 (6): 894 -898.
37. Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, Yakumaru K, Yoshizawa Y,. Expression of tissue factor in non-small cell lung cancers and its relationship to metastasis. Br J Cancer 1999; 79 (3-4): 472 -477.
38. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, Nakamura S, Shiku H,. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69 (4): 247 -254.
39. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A,. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92 (18): 8205 -8209.
40. Yu JL, May L, Klement P, Weitz JI, Rak J,. Oncogenes as regulators of tissue factor expression in cancer: Implications for tumor angiogenesis and anti-cancer therapy. Semin Thromb Hemost 2004; 30 (1): 21 -30.
41. Fernandez PM, Patierno SR, Rickles FR,. Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 2004; 30 (1): 31 -44.
42. Rickles FR, Patierno S, Fernandez PM,. Tissue factor, thrombin, and cancer. Chest 2003; 124 (3 suppl.): 58S -68S.
43. Lindholm PF, Bub J, Kaul S, Shidham VB, Kajdacsy-Balla A,. The role of constitutive NF-IB activity in PC-3 human prostate cancer cell invasive behavior. Clin Exp Metastasis 2001; 18 (6): 471 -479.
44. Hodge JC, Bub J, Kaul S, Kajdacsy-Balla A, Lindholm PF,. Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion. Cancer Res 2003; 63 (6): 1359 -1364.
45. Repesh LA,. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989; 9 (3): 192 -208.
46. Hwang YS, Hodge JC, Sivapurapu N, Lindholm PF,. Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kB activity. Mol Carcinog 2006; 45 (7): 518 -529.
47. Wahl LM, Wahl SM, Smythies LE, Smith PD,. Immunologic studies in humans. In:, Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, editors. Unit 7.6A isolation of monocyte/macrophage populations. John Wiley; 2005. 7.6.1 -7.6.3.
48. Bloom K, Harrington D,. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol 2004; 121 (5): 620 -630.
49. Ellis CM, Dyson MJ, Stephenson TJ, Maltby EL,. HER2 amplification status in breast cancer: A comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques. J Clin Pathol 2005; 58 (7): 710 -714.
50. Lee CM, Lee RJ, Hammond E, Tsodikov A, Dodson M, Zempolich K, Gaffney DK,. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: Prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis. Gynecol Oncol 2004; 93 (1): 209 -214.
51. Seto S, Onodera H, Kaido T, Yoshikawa A, Ishigami S, Arii S, Imamura M,. Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis. Cancer 2000; 88 (2): 295 -301.
52. Kakkar AK, Chinswangwatanakul V, Lemoine NR, Tebbutt S, Williamson RC,. Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma. Br J Surg 1999; 86 (7): 890 -894.
53. Ryder M, Ghossein RA, Ricarte-Filho JCM, Knauf JA, Fagin JA,. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 2008; 15 (4): 1069 -1074.
54. Pollard JW,. Macrophages define the invasive microenvironment in breast cancer. J Leukocyte Biol 2008; 84 (3): 623 -630.
55. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A,. Pathways connecting inflammation and cancer. Curr Opin Genet Dev 2008; 18 (1): 3 -10.
56. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L, Bergh A,. Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 2000; 17 (3): 445 -451.
57. Blot E, Chen W, Vasse M, Paysant J, Denoyelle C, Pille JY, Vincent L, Vannier JP, Soria J, Soria C,. Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. Br J Cancer 2003; 88 (8): 1207 -1212.
58. Mukai M, Shinkai K, Tateishi R, Mori Y, Akedo H,. Macrophage potentiation of invasive capacity of rat ascites hepatoma cells. Cancer Res 1987; 47 (8): 2167 -2171.
59. Jiang WG, Hiscox S, Hallett MB, Mansel RE, Puntis MC,. Regulation of motility and invasion of cancer cells by human monocytic cells. Anticancer Res 1995; 15 (4): 1303 -1310.
60. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C,. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004; 25 (8): 1543 -1549.
61. Siegert A, Rosenberg C, Schmitt WD, Denkert C, Hauptmann S,. Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion. Br J Cancer 2002; 86 (8): 1310 -1315.
62. Blot E, Chen W, Vasse M, Paysant J, Denoyelle C, Pille JY, Vincent L, Vannier JP, Soria J, Soria C,. Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. Br J Cancer 2003; 88 (8): 1207 -1212.
63. Karan D, Thrasher JB, Lubaroff D,. Prostate cancer: Genes, environment, immunity and the use of immunotherapy. Prostate Cancer Prostatic Dis 2008; 11 (3): 230 -236.
64. Richardsen E, Uglehus RD, Due J, Busch C, Busund LTR,. The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma. Histopathology 2008; 53 (1): 30 -38.
65. Mazzucchelli L, Loetscher P, Kappeler A, Uguccioni M, Baggiolini M, Laissue JA, Mueller C,. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathol 1996; 149 (2): 501 -509.
66. Waugh DJJ, Wilson C,. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14 (21): 6735 -6741.
67. Hernandez L, Smirnova T, Kedrin D, Wyckoff J, Zhu L, Stanley ER, Cox D, Muller WJ, Pollard JW, Van Rooijen N, Segall JE,. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Res 2009; 69 (7): 3221 -3227.
68. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J,. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004; 64 (19): 7022 -7029.
69. Ono M,. Molecular links between tumor angiogenesis and inflammation: Inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008; 99 (8): 1501 -1506.
70. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR,. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 2005; 175 (2): 1197 -1205.
71. Harkonen PL, Vaananen HK,. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann NY Acad Sci 2006; 1089: 218 -227.
72. Napoleone E, di Santo A, Peri G, Mantovani A, de Gaetano G, Donati MB, Lorenzet R,. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: Another link between inflammation and clotting activation. J Leukocyte Biol 2004; 76 (1): 203 -209.
73. Hall AJ, Vos HL, Bertina RM,. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation. J Biol Chem 1999; 274 (1): 376 -383.
74. Langer F, Chun FK-H, Amirkhosravi A, Friedrich M, Leuenroth S, Eifrig B, Bokemeyer C, Francis JL,. Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers[see comment]. Thromb Haemost 2007; 97 (3): 464 -470.
75. Kaushal V, Mukunyadzi P, Siegel ER, Dennis RA, Johnson DE, Kohli M,. Expression of tissue factor in prostate cancer correlates with malignant phenotype. Appl Immunohistochem Mol Morphol 2008; 16 (1): 1 -6.
76. Bromberg ME, Bailly MA, Konigsberg WH,. Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor. Thromb Haemost 2001; 86 (5): 1210 -1214.
77. Jiang X, Bailly MA, Panetti TS, Cappello M, Konigsberg WH, Bromberg ME,. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. Thromb Haemost 2004; 2 (1): 93 -101.
78. Hjortoe GM, Petersen LC, Albrektsen T, Sorensen BB, Norby PL, Mandal SK, Pendurthi UR, Rao LV,. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004; 103 (8): 3029 -3037.